References
- US Pharmacopeial Convention, Inc. Physical Tests. United States Pharmacopeia 27/National Formulary 22. US Pharmacopeial Convention, Inc., Rockville, MD 2003; 2350–2370
- May 27, 2004, URL: http://www.safemedication.com/meds/ShowArticle.cfm?id=3423
- US Pharmacopeial Convention, Inc. Microbiological Tests. United States Pharmacopeia 27/National Formulary 22. US Pharmacopeial Convention, Inc., Rockville, MD 2003; 2157–2162
- US Pharmacopeial Convention, Inc. Bilolgical Tests. United States Pharmacopeia 27/National Formulary 22. US Pharmacopeial Convention, Inc., Rockville, MD 2003; 2169–2173
- Hurley D. Compounder ignores FDA recall request. Pharmacy Practice News January, 2003; 1–9
- October 11, 2002, URL: http://www.thepilot.com/archives/100202TaintedDrug.html
- October 11, 2002, URL:http://www.thepilot.com/news/101102Class-Action.html
- October 11, 2002, URL:http://www.thepilot.com/news/100702SteroidCame.html
- November 20, 2002, URL:http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01171.html
- , URL:http://www.sfgate.com/cgi-in/article.cgi?file=/c/a/2002/06/23/MN12273.DTL&type=printable
- November 16, 2004, http://www.ashp.org/SterileCpd/interview.cfm?cfid=3425592&CFToken=86248059
- Kastango E S. Quality-controlled analytical methods: USP chapter<797>compounded sterile preparations sterility requirements and their relationship to beyond-use dating. IJPC 2004; 8(5)393–7
- May 28, 2004, URL:http://store.usp.org/OA_HTML/ibeCCtpItmDspRte.jsp?item=27782§ion=10071
- May 28, 2004, URL:http://store.usp.org/OA_HTML/ibeCCtpSctDspRte.jsp?section=10071